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Abstract

Possession of a higher than average number of nevi has long been substantiated as
one of several factors that predispose patients to malignant melanoma. Despite the
relative certainty of this relationship, little is known about the relationship between the
number of nevi a person possesses and risk of death from melanoma. A cohort of
melanoma patients was followed prospectively to determine if a significant relationship
exists between number of nevi and increased mortality from melanoma. Age at
diagnosis, melanoma of the head and neck, increasing Breslow thickness and presence of
mitoses all were associated with poorer survival in our multivariate analysis. Existence
of a dermal nevus at the site of melanoma was also associated with poorer survival, while
solar elastosis and skin awareness were associated with improved survival. Our study
also suggests that having a large number of nevi increases the risk of death from
melanoma more than two-fold. Further research elucidating the prognostic indications of
a high number of nevi possessed by melanoma patients could potentially lead to
considerable advances in the classification, diagnosis, and therapy for cutaneous
melanoma.
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Introduction

Individuals who have many nevi are at higher risk for developing melanoma. In
fact, a large number of nevi has been shown to be the strongest known risk factor for
developing melanoma among Caucasians (Armstrong, 2004). Even in the absence of
clinically atypical nevi, a very high number of nevi (e.g., more than 100) have been
shown to significantly increase risk for melanoma (Huynh et al., 2003). Risk is based on
the total number of nevi, not those at a particular anatomic site (Weinstock et al., 1989).

Survival among melanoma patients has been shown to be influenced by
pathologic characteristics such as tumor thickness (Breslow depth), histogenetic subtype,
Clark level, microscopic satellites, ulceration, vascular invasion, mitotic rate and growth
phase (Barnhill et al., 1996). Regression and solar elastosis have been shown to be
protective (Barnhill et al., 1996; Berwick et al., 2005). Tumor thickness is probably the
most important pathologic prognostic factor in localized, cutaneous melanoma (Lemish et
al., 1983; Heenan et al., 1991; Barnhill et al., 1996; Berwick et al., 2005). In an analysis
of prognostic factors for 17,600 melanoma patients, increasing tumor thickness was
highly correlated with 10-year melanoma specific mortality (p<0.00001) (Balch et al.,
2001). In one study, level of awareness of skin alterations is associated with improved
survival and is probably another important prognostic factor (Berwick et al., 1996). It is
not clear that early detection of melanoma through skin self-examination reduces
mortality, but one study indicated that it may decrease risk by up to 63% (Berwick et al.,
1996). Melanoma has been associated with a worse prognosis when the site of origin is
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the head or neck as opposed to the extremities (Lemish et al., 1983) and females have
been shown to have a higher survival rate than males (Clark et al., 1989). These
prognostic factors are potential confounders of survival studies. Despite the existence of
extensive research that documents the risk for developing malignant melanoma with
increasing numbers of nevi, a relationship between number of nevi and survival with
melanoma has yet to be identified.

Although the number of nevi has been shown to be determined by genetic factors,
(Zhu et al., 1999; Bataille et al., 2000) environmental factors are also important for nevus
development (Kefford et al., 2004). Epidemiological studies in several countries have
shown that exposure to excessive sunlight in childhood is associated with total number of
nevi. Habitual sun exposure, (Darlington et al., 2002) severe sunburns, (Green et al.,
1986; Dennis et al., 1996; Valiukeviciene et al., 2005) recent chronic sun exposure
(Armstrong et al., 1986) and total cumulative sun exposure (Weiker et al., 2003; Bauer et
al., 2005) have all been proposed as important types of sun exposure associated with
increasing number of nevi. Tendency to burn (Green et al., 1986; Heenan et al., 1991;
Whiteman et al., 2005), freckling (Green et al., 1986; Darlington et al., 2002; Whiteman
et al., 2005), light eye color (Whiteman et al., 2005; Wachsmuth et al., 2005), light hair
color (Whiteman et al., 2005; Wachsmuth et al., 2005), and light skin color (Patvlotsky et
al., 1997; Whiteman et al., 2005) have also all been positively associated with number of
nevi, although these findings vary between studies. A higher prevalence of nevi has been
found among individuals with moderately dark skin compared to the those with pale skin
(Armstrong et al., 1986). Increasing age has been shown to be associated with a
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decreasing number of nevi (Green et al., 1986; Dennis et al., 1996; Schafer et al., 2006)
and individuals with melanoma arising from the head or neck tend to have fewer nevi
than those with melanoma arising on the trunk (Whiteman et al., 2003).

We wanted to examine whether nevi might be a marker for a type of melanoma
that has escaped growth controls and thus might be associated with survival with the
disease. Therefore, we conducted long-term follow up (average 16 years) of subjects
who had been enrolled in a population-based case control study in Connecticut (Berwick
et al., 1996; Berwick et al., 2005).

Methods

The original study on melanoma was approved by the Institutional Review Boards
at Yale University, the State of Connecticut Department of Health and the University of
New Mexico Health Sciences Center, as well as the hospitals where patients had been
diagnosed. Potential subjects with melanoma were identified through the Rapid Case
Ascertainment System (RCA), a shared resource of the Cancer Prevention Research Unit
for Connecticut and acts as an agent of the Connecticut Tumor Registry (CTR). All
participating subjects signed informed consent. Eligibility was based on diagnosis of a
first primary invasive melanoma between the dates of January 15, 1987 and May 15,
1989, residence in the state of Connecticut, being of Caucasian race, and being 18 years
old or greater. All biopsies and re-excisions were reviewed by a single
dermatopathologist (R.L. Barnhill) for standardization. 650 eligible patients, or 75% of
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those eligible, were interviewed and of these nevus counts were obtained for 80 percent
of subjects

Trained, registered nurses conducted in-person interviews with all the selected
study participants. They interviewed the patients with a structured questionnaire to assess
the following information: age at melanoma diagnosis, sex, level of educational
attainment, history of severe sunburns, skin examination practices, skin awareness, site of
melanoma, use of sunlamps, sunscreen use within the last 10 years, sunscreen use before
age 15, tanning ability, skin color, and lifetime intermittent sun exposure. The sun
exposure index that we used quantified sun exposure history by summing the total
intermittent recreational sun exposure histories and has been previously described in
detail (Berwick et al., 1996). Intermittent sun exposure was measured as described
previously (Berwick et al., 1996). Nurses trained in techniques of skin examination
recorded skin color on the inner aspect of the upper arm. Information regarding skin
type, sunburn history, skin examination and skin awareness was gathered by asking the
following questions:

Skin type. After repeated and prolonged exposure to sunlight, would your skin
become: tan, very brown and deeply tanned or moderately tanned or only mildly tanned
due to a tendency to peel; no tan, only freckled or no suntan at all.

Sunburn history. Have you ever been sun burnt severely enough to cause pain
for 2 or more days or blisters?
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Skin examination. Individuals were classified as skin self-examiners if they
answered positively to either of the following two questions: 1) Did you ever (in your
life) carefully examine your own skin? By this I mean actually check surfaces of your
skin deliberately and purposefully?; or 2) Has someone other than a physician ever
carefully examined areas of your skin on purpose?

Skin awareness. [Before your recent biopsy] did you ever think about your skin,
how it looked, whether there were any changes, or whether there were any abnormal
marks? Individuals that answered that they were aware of changes or abnormalities were
classified as having skin awareness, while those that answered negatively or answered
that they were aware only of cosmetic or other changes were not classified as having skin
awareness.

The trained, registered nurses also counted and recorded nevi greater than 2mm in
largest diameter on the arms and backs of subjects who consented. A standardized
method was used that only included the counting of nevi proximal to the styloid process
on both arms. Each arm was divided into four sections and the nurses recorded which
sections were examined for nevi. Flat nevi of 2 mm or more in diameter and greater were
recorded, and raised nevi of any size were included if they were visibly raised. Nevus
counts were performed in an organized fashion beginning with the counting of raised true
nevi on both arms followed by inspection for junctional or lentigo simplex nevi and
finally, nevi 5mm or greater in largest diameter were counted for both arms. The patients
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were examined for palpable nevi by visual inspection first, while palpation was only
utilized to distinguish between raised and flat nevi. Inspection of the arms was concluded
with observation and recording of the color of the skin on the inner aspect of the upper
arm of the patient (dark/black, moderately dark, medium, fair, very fair). The back was
assessed in a similar manner and the proportion of the back that was able to be examined
was noted by the interviewer and classified as one the following categories: none, all,
upper quarter, upper half, and upper ¾ of the back. This allowed for the differences in the
proportion of the back that was examined to be taken into account in the analysis. All
large nevi on the arms and back were diagramed by the interviewer and the largest mole
from the patient’s back was recorded on a mannequin.

Pathologic characteristics of melanoma that were recorded included tumor
thickness, number of mitoses per millimeter squared (mitotic index), presence of solar
elastosis, and Clark level. Presence of a co-existing nevus and the type of nevus (dermal,
congenital, dysplastic and other) was also recorded. Follow-up was performed by the
RCA throughout the study period up until the August 2008 in all diagnosing institutions
in Connecticut. Follow-up included a review of death certificates and reports to the CTR,
as well as mailings and telephone calls to patients, their spouses, and their primary
physicians if necessary. The National Death Index was queried for all those for whom
we did not have death certificates. The median follow up for all case subjects was 16.1
years and the range was 0 to 19.9 years.
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Statistical analysis consisted of frequency distributions, and cross-tabulations.
Covariates that were determined to have a significant correlation with number of nevi
were included in univariate models measuring death as the outcome. If the p-value from
a specific univariate model was less than 0.16, then that covariate was included in the
multivariate analysis, using Cox proportional hazard modeling with time to mortality
from melanoma as the outcome. Potential confounders were assessed by comparing the
hazard ratio for survival and nevi with each variable that might modify the hazard ratio
by 15% or more.

We evaluated the distribution of nevi and divided nevi into two groups based on
the top 25th percentile and the lower 75th percentile. We then compared selected
variables by the two groups of nevi (Table 1). The following covariates were included:
sex, age at diagnosis, ability to tan, history of sunburn, skin color, presence of solar
elastosis (a histologic indicator of cutaneous sun damage), anatomic site of melanoma,
history of sun exposure, skin examination, sunlamp use, tumor thickness, presence of
mitosis, Clark level, education, co-existing nevus, dermal nevus and skin awareness.

Results

In follow up of this cohort, 98 (18.8%) of the 520 patients died of melanoma and
126 (24.2%) died of other causes over the twenty-year period. Younger participants were
significantly more likely to possess more than 28 nevi on their arms and back (P = <.01)
as were those with the ability to tan after prolonged sun exposure (P = .03). Individuals
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with melanoma arising from the head or neck were significantly more likely to be in the
low nevus group (P = .01). Skin examination was associated with more nevi (P = .07)
and solar elastosis was associated with fewer nevi (P = .05), but these were of borderline
significance. Time to death from melanoma was modeled using univariate Cox hazard
models to obtain the hazard ratio for each covariate (Table 2). Eleven variables were
significant in this analysis. High nevus count was associated with an increased risk of
death from melanoma (HR = 1.7, 95% CI = 1.1 to 2.6, P = .01). Men were more likely to
die from melanoma than were women (HR = 1.5, 95% CI = 1.0 to 2.3, P =.04).
Increasing age at diagnosis was associated with a decrease in survival (HR for every 1year increase in age = 1.02, 95% CI = 1.01 to 1.03, P = < .01), as was melanoma of the
head and neck compared to melanoma of other sites (HR= 1.8, 95% CI = 1.1 to 3.0, P =
.02), the presence of mitoses (HR = 8.9, 95% CI = 4.3 to 18.3, P = <.01), and increasing
Breslow thickness and Clark level (see Table 2). Several factors associated with sun
exposure were protective: A higher amount of sun exposure (HR for heavy or very heavy
sun exposure compared to light or moderate sun exposure = 0.6, 95% CI = 0.4 to 0.9, P =
0.02), the use of sunlamps (HR = 0.3, 95% CI = 0.2 to 0.7, P = <0.01), skin awareness
(HR = 0.5, 95% CI = 0.3 to 0.8, P = <0.01) and education greater than high school (HR =
0.7, 95% CI = 0.4 to 1.0, P = .03). The presence of solar elastosis was also protective
(HR = 0.7, 95% CI = 0.5 to 1.0, P = .06) but of borderline significance. Additional
covariates in the univariate analyses were prognostic, but not statistically significant:
The presence of a dermal nevus at the site of melanoma (HR = 1.5, 95% CI = 0.9 to 2.5,
P = 0.16) and history of a severe sunburn (HR = 0.7, 95% CI = 0.5 to 1.1, P = 0.14).
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For the multivariate analysis (Table 3), we included all variables from the
univariate models (Chi-square and Cox univariate) with a P value ≤ 0.16. Sex was forced
into the model due to its importance in the literature as a prognostic indicator for death
from melanoma. Clark level was excluded from the multivariate analysis because Clark
level and Breslow thickness had a Spearman correlation coefficient of 0.79 and were
considered to be collinear. In multivariate analysis a high number of nevi (HR = 2.4,
95% CI 1.5-3.7), older age at diagnosis (HR = 1.03, 95% CI 1.01-1.04, melanoma on the
head or neck (HR = 2.0, 95%, CI = 1.2 to 3.4), presence of solar elastosis (HR = 0.6,
95%, CI = 0.3 to 0.9), greater Breslow thickness (HR for 0.76 mm to ≤3.60 mm = 3.1,
95% CI = 1.9 to 5.2; HR > 3.60mm = 4.7, 95% CI = 2.6 to 8.5), any mitoses (HR = 4.2,
95% CI 1.9-9.1) , presence of a dermal nevus (HR = 1.8, 95%, CI = 1.0 to 3.3), and skin
awareness (HR = 0.5, 95%, CI = 0.3 to 0.9) were all significantly associated with
melanoma mortality.

Discussion

The results of this melanoma mortality study with twenty years of follow up
further support the significance of previously known prognostic indicators. In our
multivariate analysis, age at diagnosis, melanoma of the head and neck, increasing
Breslow thickness and presence of mitoses all were associated with poorer survival.
Existence of a dermal nevus at the site of melanoma was also associated with poorer
survival in our study, but to our knowledge this characteristic has not been well studied.
Presence of solar elastosis and skin awareness were associated with improved survival, as
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was noted in a five-year follow-up study using the same patient database (Berwick et al.,
2005). Interestingly, our study suggests that having a large number of nevi increases the
risk of death from melanoma more than two-fold. The association of increasing number
of nevi with mortality from melanoma was independent of its significant associations
with age at diagnosis, skin type and anatomic site of melanoma. In the previous five-year
follow-up study with this data, the association between nevus counts and death from
melanoma was not statistically significant (Berwick et al., 2005), but this has changed
with the longer follow-up period. To our knowledge, number of nevi has not previously
been evaluated as a prognostic factor.

In the US, New Zealand and Canada, incidence rates of the more aggressive
melanoma on the ears, scalp and neck were higher in males compared to females
(Bulliard et al., 1997). The differences in common melanoma sites between males and
females likely reflects distinct patterns of site-specific UV radiation (Green et al., 1993;
Bulliard et al., 1997; Elwood et al., 1998).

There are multiple factors that could confound the association between nevi and
mortality. For example, age is related to both mortality and number of nevi, because as
people age past a certain point, their chance of dying tends to increase, while their
number of nevi tends to decrease (Dennis et al., 1996). These factors might mitigate
against each other. Inevitably, additional confounders may exist that could potentially
contribute to error in the study. For example, there is a possibility that use of sunscreen
and protective clothing could be inversely associated with mortality from melanoma.
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These variables were not included in the multivariate analysis even though their
quantification was attempted in the survey but people generally have poor memory of
these factors and in a reproducibility study, sunscreen use was not reliably recalled
(unpublished data).1 In addition, sunscreen use was not frequent in the 1980’s, when the
study was conducted. Other data that were gathered, such as sun exposure, could be
relatively unreliable either because of recall bias or because people simply have poor
memories of sunburn history. Finally, nevus counts are complete for only 80% of the
cohort, because this process was initiated after the study had begun.

Despite the presence of certain limitations in this study, there are a number of
inherent strengths. The fifteen-year follow-up allowed for a greater number of outcomes
of interest (death) as compared to a previous study using the same data with a five-year
follow-up. The long time frame also increased the chance that covariate patterns related
to mortality of melanoma would be elucidated and adjusted for more appropriately. The
study design strengthened the analysis of our data because a comprehensive initial survey
was used to collect information from participants. A unique feature of this study was that
skin examination characteristics were collected and could be adjusted for in the
multivariate analysis. The vital status for participants who did not respond to mailed
follow-up questionnaires was ascertained by phone calls to the patient, patient’s spouse
or patient’s physician. Using this method instead of solely relying upon death certificate
information minimized misclassifications of cause of death, which allowed for more
complete and accurate evaluation of the relationship between number of nevi and
1

Berwick M, unpublished data. A kappa for memory of sunscreen use was 0.1
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survival. Finally, the use of a single pathologist for the collection of melanoma
characteristics such as associated solar elastosis and Clark level also helped to
standardize results and avoid inter-observer variation.

The association of a high number of nevi with increased mortality from melanoma
may be explained by two hypotheses. First, a separate, more aggressive oncogenic
pathway may be associated with patients in the high nevi group. The divergent pathway
model developed by Whiteman classifies the pathogenesis of melanoma into two
pathways, one characterized by environmental induction and p53 over-expression and
another characterized by pigment cell instability (Whiteman et al., 1998). It has been
suggested that individuals with fewer nevi require repeated exposure to sunlight in order
to drive carcinogenesis because they are more likely to develop melanomas on high sun
exposure areas such as the head and neck, while those with many nevi, who are more
likely to develop melanoma of the trunk, may possess host factors that drive
carcinogenesis after minimal sunlight exposure (Whiteman et al., 2003). Therefore, it is
plausible that the oncogenic pathway characterized by pigment cell instability is
associated with a higher number of nevi, and may lead to more aggressive melanoma and
a worse prognosis.

Alternatively, the pathogenesis of melanoma in patients of both the high and low
nevi groups may follow very similar pathways, but patients in the high nevi group may be
missing a genetic checkpoint. The absence of this checkpoint may allow for a more
aggressive progression of melanoma and may also permit the development of a higher
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number of nevi. The etiology of nevi and melanoma appear to be similar in some
respects, as the gene CDKN2A has been associated with the development of melanoma
(Kefford et al., 1999; Zhu et al., 1999; Chaudru et al., 2004) and possibly with the
development of nevi as well (Zhu et al., 1999). For example, a subset of people with
certain familial nevus disorders such as dysplastic nevus syndrome (DNS) possess a
CDKN2A mutation and go on to develop melanoma (Zhu et al., 1999). Further
characterization of the biochemical pathways leading to the development of both nevi and
melanoma will be necessary, however, before either of these hypothesis can be
appropriately supported.

In summary, we found that a high number of nevi is associated with poorer
survival from melanoma, though little is known about the specific mechanism by which
this may occur. Confirmation of our results may contribute to evidence in the field of
oncology that suggests that genetic susceptibility in patients with cancer may possess
distinct features of natural history that affect prognosis. Prognostic variables that can be
inexpensively and non-invasively obtained from patients may provide welcome new
capabilities in clinical medicine. A related example is the finding that women who were
diagnosed with breast carcinoma and who had a first-degree family history of breast
carcinoma had half the risk of dying compared to those in sporadic cases (Malone et al.,
1996). Like family history, the number of nevi present on a patient can easily be
obtained clinically. Further research elucidating the prognostic implications of a high
number of nevi in melanoma patients could potentially lead to advances in the
classification, diagnosis, therapy, and prognosis of melanoma.
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1. Effect of covariates on nevus count.
Number of Nevia
Low (n =453) High (n = 96)
n (%)
n (%)
Sex
Male
Female
Age at diagnosis
<30
30-39
40-49
50-59
60-69
70+
Skin type
Tan
No tan
Skin color
Very fair/fair
Medium
Anatomic site
Head and neck
Other
Solar elastosis
Absent
Present
Breslow thickness
< 0.76
0.76 – 1.69
1.70 – 3.60
> 3.60
Clark level
II
III
IV
V
Mitotic figure(s)
Absent
Present
Co-existing nevus
Yes
No
Dermal nevus2
Yes
No
Total sun exposure
Light/moderate
Heavy/very heavy
Severe sunburn
Yes
No
Sunlamp use
Yes
No
Education
Up to high school
Greater than
high school
Skin examination
Yes
No
Skin awareness
Yes
No
2

P value

194 (72.9)
197 (77.6)

72 (27.1)
57 (22.4)

.22

19 (79.2)
47 (64.4)
59 (62.1)
79 (76.0)
90 (81.8)
97 (85.1)

5 (20.8)
26 (35.6)
36 (37.9)
25 (24.0)
20 (18.2)
17 (14.9)

<.01

240 (72.1)
139 (80.8)

93 (27.9)
33 (19.2)

.03

277 (75.3)
114 (79.1)

91 (24.7)
38 (20.9)

.95

65 (86.7)
326 (73.3)

10 (13.3)
119 (26.7)

.01

135 (71.1)
236 (80.4)

55 (28.9)
69 (19.6)

.05

174 (75.7)
113 (73.4)
65 (74.7)
36 (78.3)

56 (24.3)
41 (26.6)
22 (25.3)
10 (21.7)

.91

139 (80.3)
101 (71.6)
124 (72.5)
15 (75.0)

34 (19.7)
40 (28.4)
47 (27.5)
5 (25.0)

.26

149 (74.9)
216 (76.4)

50 (25.1)
78 (23.6)

.73

110 (71.0)
261 (75.9)

45 (29.0)
83 (24.1)

.25

43 (69.4)
332 (75.1)

19 (30.6)
110 (24.9)

.33

150 (79.4)
232 (72.5)

39 (20.6)
88 (27.5)

.08

264 (77.4)
125 (70.6)

77 (22.6)
52 (29.4)

.09

87 (77.0)
304 (74.7)

26 (23.0)
103 (25.3)

.62

157 (75.5)
234 (75.0)

51 (24.5)
78 (25.0)

.90

95 (69.3)
296 (77.3)

42 (30.7)
87 (22.7)

.07

119 (75.8)
272 (74.9)

38 (24.2)
91 (25.1)

.83

Dermal nevus is a subset of co-existing nevus. Please see text.
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2. Predictors of risk of death from melanoma in a population-based study of residents
from Connecticut.

Variable
Number of nevi
< 28
28+
Sex
Female
Male
Age at diagnosis4
1-year increase
Skin type
No tan
Tan
Skin color
Medium
Very fair/fair
Anatomic site
Other
Head and neck
Solar elastosis
Absent
Present
Breslow thickness
< 0.76
0.76 – 1.69
1.70 – 3.60
> 3.60
Clark level
II
III
IV/V
Mitotic figure(s)
Absent
Present
Co-existing nevus
No
Yes
Dermal nevus
No
Yes
Total sun exposure
Light/moderate
Heavy/very heavy
Severe sunburn
No
Yes
Sunlamp use
No
Yes
Education
Up to high school
Greater than
high school
Skin examination
No
Yes
Skin awareness
No
Yes

3
4

Total
no.3

No. of
Hazard ratio
melanoma (95% confidence
deaths
interval)

171
53

64
34

1.0 (referent)
1.7 (1.1 to 2.6)

.01

85
139

40
58

1.0 (referent)
1.5 (1.0 to 2.3)

.04

1.02 (1.01 to 1.03)

<.01

P value

75
139

31
62

1.0 (referent)
1.0 (0.6 to 1.5)

1.0

63
161

25
73

1.0 (referent)
1.3 (0.8 to 1.0)

.30

174
50

77
21

1.0 (referent)
1.8 (1.1 to 3.0)

.02

64
152

46
49

1.0 (referent)
0.7 (0.5 to 1.0)

.06

76
59
53
35

10
28
37
23

1.0 (referent)
4.3 (2.1 to 8.9)
12.4 (6.2 to 25.0)
17.9 (8.5 to 37.6)

<.01
<.01
<.01

53
57
107

4
23
65

1.0 (referent)
7.5 (2.6 to 21.6)
17.9 (6.5 to 49.2)

<.01
<.01

65
150

8
88

1.0 (referent)
8.9 (4.3 to 18.3)

<.01

156
59

65
29

1.0 (referent)
1.0 (0.6 to 1.5)

.97

191
27

80
16

1.0 (referent)
1.5 (0.9 to 2.5)

.16

109
108

43
50

1.0 (referent)
0.6 (0.4 to 0.9)

.02

81
142

39
59

1.0 (referent)
0.7 (0.5 to 1.1)

.14

189
35

89
9

1.0 (referent)
0.3 (0.2 to 0.7)

<.01

111
113

47
51

1.0 (referent)
0.7 (0.4 to 1.0)

.03

175
49

74
24

1.0 (referent)
.9 (0.6 to 1.4)

.60

169
55

80
18

1.0 (referent)
0.5 (0.3 to 0.8)

<.01

Numbers may vary because of missing data for some variables.
Age is continuous variable.
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3. Independent predictors of death from melanoma in a multivariable model.5
Variable
Number of nevi
<30
30+
Sex6
Female
Male
Age at diagnosis
1-year increase
Anatomic site
Other
Head/Neck
Solar elastosis
Absent
Present
Breslow thickness
< 0.76
≤3.60
> 3.60
Mitoses
None
Any
Dermal nevus
No
Yes
Skin awareness
No
Yes

5
6

Hazard ratio (95% confidence interval)

P value

1.0 (referent)
2.4 (1.5 to 3.7)

<.001

1.0 (referent)
1.1 (0.7 to 1.6)

.82

1.03 (1.01 to 1.04)

<.001

1.0 (referent)
2.0 (1.2 to 3.4)

.01

1.0 (referent)
0.6 (0.3 to 0.9)

.01

1.0 (referent)
3.1 (1.9 to 5.2)
4.7 (2.6 to 8.5)

<.001
<.001

1.0 (referent)
4.2 (1.9 to 9.1)

<.001

1.0 (referent)
1.8 (1.0 to 3.3)

.04

1.0 (referent)
0.5 (0.3 to 0.9)

.01

This model was run with all variables with P < .15 in table 2. Variables that remained statistically significant are shown.
Sex was forced into the model.
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